"10.1371_journal.pone.0129555","plos one","2015-06-19T00:00:00Z","Simon Thebault; Patrick Waters; Matthew D Snape; Dominic Cottrell; Niklas Darin; Tove Hallböök; Anne Huutoniemi; Markku Partinen; Andrew J Pollard; Angela Vincent","Neuroimmunology Group, Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, United Kingdom; Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom; The NIHR Oxford Biomedical Centre, Oxford University Hospitals Trust, Oxford, United Kingdom; Imperial College of Medicine, University of London, London, United Kingdom; Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Helsinki Sleep Clinic, Finnish Narcolepsy Research Centre, Helsinki, Finland; Department of Clinical Neurosciences, University of Helsinki, Helsinki, Finland","Conceived and designed the experiments: ST PW MDS ND TH AH MP AJP AV. Performed the experiments: ST PW AV. Analyzed the data: ST PW AV. Contributed reagents/materials/analysis tools: MDS DC ND TH AH MP AJP AV. Wrote the paper: ST PW MDS DC ND TH AH MP AJP AV.","ST, DC, ND, AH and TH declare no competing interests. PW is a co-inventor on a patent relating to assays for the detection of antibodies to LGI1, CASPR2, and Contactin2, and has received royalties. MDS has been an investigator for studies sponsored by GlaxoSmithKline, Novartis Vaccines, Pfizer, and Sanofi Pasteur and has participated in advisory boards for these companies; all payments for such services are made to the University of Oxford Department of Paediatrics. MP speaks and consults for UCB Pharma, and speaks for Leiras Takeda, and Cephalon, unrelated to this research. AJP, unrelated to this research, has previously received grant/research support from GlaxoSmithKline, Novartis Vaccines, Pfizer, and Sanofi Pasteur. AV, related to this research, with the University of Oxford holds patents and receive a proportion of royalties for CASPR2 antibody assays; unrelated to this research has received grant funding from GSK. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.","2015","06","Simon Thebault","ST",10,FALSE,9,3,3,10,TRUE,TRUE,FALSE,0,NA,FALSE
